• Investment World
• eWorld
• Brand Line
• Mentor
• Life
• Canvas
• Praxis
• Urban Pulse
• Brand Quest
• The New Manager

Stocks

• Quotes
• SE Diary
• Scoreboard
• Open-End Mutual Fund

Cross Currency

• Rates
  
  

Shipping

• Ports
  
  

Archives

• Yesterday
• Datewise
• Resources
• In Focus
• In Depth

Group Sites

• The Hindu
• The Hindu ePaper
• Business Line
• Business Line ePaper
• Sportstar
• Frontline
• The Hindu eBooks
• The Hindu Images

Our Bureau

Bangalore May 2 Manipal AcuNova Ltd has said it has received the Frost & Sullivan Partner of Choice award for bio-availability and bio-equivalence (BA/BE) studies.

A release quoting Mr D.A. Prasanna, Vice-Chairman and MD of the contract research organisation, said, "This award is an assurance of global quality to our clients. India has emerged as a key destination for conducting clinical research. We are proud to be benchmarked by Frost & Sullivan in a field [where] there are several Indian players."

An F&S team visited Manipal AcuNova's centres at Bangalore, Mangalore and Manipal to evaluate it on criteria such as technical know-how of the personnel; value added services to customers; quality initiatives; responsiveness and significance of the technology in the industry.

Bio-availability (BA) is conducted on healthy human volunteers to demonstrate and prove that the study drug is biologically equivalent to the innovator drug and can be allowed for marketing in the same manner for the same indications. BA/BE studies are conducted to reduce the cost of treatment by producing generic lower-cost versions of an innovator drug molecule.

More Stories on : Awards & Honours | Pharmaceuticals | Research & Development | Karnataka

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page

Stories in this Section
Goldstone hiking borrowing limit

Copyright © 2007, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line